May 28, 2020 ProMIS Neurosciences and collaborative team receive Supercluster Award supporting avoidance of future pandemics by new strains of the COVID-19 virus
May 20, 2020 ProMIS Neurosciences Chairman’s Update details new programs from expanded use of novel technology platform
May 19, 2020 ProMIS Neurosciences and BC Neuroimmunology expand collaboration to develop and commercialize proprietary diagnostic assays
May 12, 2020 ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for development of a highly accurate COVID-19 antibody test
May 6, 2020 ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous neurodegenerative diseases, including ALS
Apr 30, 2020 ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other neurodegenerative diseases
Apr 15, 2020 ProMIS Neurosciences announces collaboration to develop serological test to assess COVID-19 immunity
Apr 9, 2020 Journal of the American Academy of Neurology Publishes ProMIS Neurosciences’ Abstracts on Novel Antibody Candidates